Header Logo

Connection

Virender Rehan to Pulmonary Alveoli

Back to Details
This is a "connection" page, showing publications Virender Rehan has written about Pulmonary Alveoli.
Virender Rehan
Connection Strength
5.675
Pulmonary Alveoli
  1. Antenatal PPAR-? agonist pioglitazone stimulates fetal lung maturation equally in males and females. Am J Physiol Lung Cell Mol Physiol. 2020 09 01; 319(3):L435-L443.
    View in: PubMed
    Score: 0.637
  2. On the evolution of the pulmonary alveolar lipofibroblast. Exp Cell Res. 2016 Jan 15; 340(2):215-9.
    View in: PubMed
    Score: 0.465
  3. Perinatal nicotine exposure suppresses PPAR? epigenetically in lung alveolar interstitial fibroblasts. Mol Genet Metab. 2015 Apr; 114(4):604-12.
    View in: PubMed
    Score: 0.438
  4. The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury. Antioxid Redox Signal. 2014 Nov 01; 21(13):1893-904.
    View in: PubMed
    Score: 0.412
  5. Neutral lipid trafficking regulates alveolar type II cell surfactant phospholipid and surfactant protein expression. Exp Lung Res. 2011 Aug; 37(6):376-86.
    View in: PubMed
    Score: 0.342
  6. Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts. Exp Lung Res. 2011 Apr; 37(3):144-54.
    View in: PubMed
    Score: 0.328
  7. 1alpha,25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis. Am J Physiol Lung Cell Mol Physiol. 2009 Sep; 297(3):L496-505.
    View in: PubMed
    Score: 0.297
  8. Effect of maternal food restriction on fetal rat lung lipid differentiation program. Pediatr Pulmonol. 2009 Jul; 44(7):635-44.
    View in: PubMed
    Score: 0.297
  9. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol. 2009 Jun; 296(6):L1031-41.
    View in: PubMed
    Score: 0.292
  10. In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism. Am J Physiol Lung Cell Mol Physiol. 2007 Jan; 292(1):L323-33.
    View in: PubMed
    Score: 0.250
  11. Evidence for the presence of lipofibroblasts in human lung. Exp Lung Res. 2006 Sep; 32(8):379-93.
    View in: PubMed
    Score: 0.244
  12. Does "A" stand for alveolization? Eur Respir J. 2004 Jan; 23(1):3-4.
    View in: PubMed
    Score: 0.203
  13. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab. 2002 May; 76(1):46-56.
    View in: PubMed
    Score: 0.181
  14. Inhaled vitamin A is more effective than intramuscular dosing in mitigating hyperoxia-induced lung injury in a neonatal rat model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2020 09 01; 319(3):L576-L584.
    View in: PubMed
    Score: 0.160
  15. A Combination of the Aerosolized PPAR-? Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats. Neonatology. 2018; 113(4):296-304.
    View in: PubMed
    Score: 0.135
  16. Pathological case of the month. Congenital alveolar capillary dysplasia and misalignment of lung vessels. Arch Pediatr Adolesc Med. 1997 Nov; 151(11):1163-4.
    View in: PubMed
    Score: 0.132
  17. Evidence for the involvement of fibroblast growth factor 10 in lipofibroblast formation during embryonic lung development. Development. 2015 Dec 01; 142(23):4139-50.
    View in: PubMed
    Score: 0.115
  18. Nebulized PPAR? agonists: a novel approach to augment neonatal lung maturation and injury repair in rats. Pediatr Res. 2014 May; 75(5):631-40.
    View in: PubMed
    Score: 0.102
  19. Curcumin protects the developing lung against long-term hyperoxic injury. Am J Physiol Lung Cell Mol Physiol. 2013 Aug 15; 305(4):L301-11.
    View in: PubMed
    Score: 0.098
  20. A cell-molecular approach predicts vertebrate evolution. Mol Biol Evol. 2011 Nov; 28(11):2973-81.
    View in: PubMed
    Score: 0.085
  21. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol. 2010 Nov; 299(5):L672-80.
    View in: PubMed
    Score: 0.080
  22. Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res. 2009 Feb; 65(2):150-5.
    View in: PubMed
    Score: 0.072
  23. Reversal of nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of parathyroid hormone-related protein signaling. Lung. 2007 May-Jun; 185(3):151-9.
    View in: PubMed
    Score: 0.064
  24. Prevention of bronchopulmonary dysplasia: finally, something that works. Indian J Pediatr. 2006 Nov; 73(11):1027-32.
    View in: PubMed
    Score: 0.062
  25. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pulmonol. 2006 Jun; 41(6):558-69.
    View in: PubMed
    Score: 0.060
  26. Deconvoluting lung evolution using functional/comparative genomics. Am J Respir Cell Mol Biol. 2004 Jul; 31(1):8-12.
    View in: PubMed
    Score: 0.053
  27. The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr Pathol Mol Med. 2003 May-Jun; 22(3):189-207.
    View in: PubMed
    Score: 0.048
  28. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-? agonist rosiglitazone. Am J Physiol Lung Cell Mol Physiol. 2011 Jul; 301(1):L125-34.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.